Drugs / 1,25(OH)2 Vitamin D3
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02005302 Comparator | Jan 2013 → Dec 2015 | protein-energy malnutrition, vitamin D deficiency | Wenhu Liu | Unknown | No outcome recorded |
| Phase 4 | NCT01633853 Comparator | Jul 2012 → Sep 2015 | vitamin D deficiency | Dongliang Zhang, MD | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 1,25(OH)2 Vitamin D3 | “Patients will be treated by 1,25(OH)2 Vitamin D3. Oral 1,25(OH)2 Vitamin D3(Rocaltrol) by 0.25 microgram once daily at start and regulate the dose according to the changes of...” NCT01633853 ↗ |
| Route | Oral | “Oral 1,25(OH)2 Vitamin D3(Rocaltrol) by 0.25 microgram once daily at start” NCT01633853 ↗ |